Novavax and Moderna shares have started to fall. The reasons are as follows: Novavax has postponed its application to the FDA, and its quarterly report is weak, while Moderna shares are naturally correcting. Tech analysis of Novavax and Moderna shares.
On July 21st, Moderna will join the S&P 500 index. This news made its shares go up by over 10%. Tech analysis of Moderna shares for July 19th, 2021.